Iron infusion to improve recovery after gynecologic cancer surgery
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and can sign consent
- You’re scheduled for planned major gynecologic oncology surgery that lasts 1 hour or more
- Your surgery is expected within 28 to 90 days after joining the study
- Your pre-surgery blood test shows low hemoglobin (<120 g/L) and low iron saturation (TSAT <20%)
- You can receive the study infusion at least 21 days but no more than 90 days before surgery
- If you can become pregnant, you must have a negative pregnancy test and use reliable birth control through the study and for 6 weeks after the infusion
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
This trial tests whether giving iron through a vein before surgery helps people with stomach (gastric) cancer who need an operation. It may be aimed at improving iron levels around the time of gastrectomy (stomach removal).
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
This trial tests a single dose of intravenous iron given after heart surgery to see if it helps prevent or reduce long-term anemia. It is for adults who already have low iron or anemia before surgery and who remain anemic the day after surgery.
This trial tests whether giving iron through a vein can help people with colorectal cancer who have low iron stores but are not anemic. It looks at patients scheduled for curative colon or rectum surgery.
This trial tests a combination of medications (intravenous iron, EPO, and tranexamic acid) given before surgery to help manage anemia or iron deficiency in people with bone tumors. The goal is to improve blood counts and reduce the need for transfusions during recovery.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.